+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cough, Cold and Allergy (Hay Fever) Remedies in Norway

  • PDF Icon

    Report

  • 26 Pages
  • September 2023
  • Region: Norway
  • Euromonitor International
  • ID: 227116
Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered stable and consistently positive sales growth throughout the review period. Rising sales during 2023 were driven largely by the return to normal schedules and lifestyle habits during the post-pandemic era.

The analyst's Cough, Cold and Allergy (Hay Fever) Remedies in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage:
Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NORWAYKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Steady sales growth for the largest OTC category due to the return of social lives
  • Slower growth for some categories in 2023 after a particularly strong showing in 2022
  • Antihistamines/allergy remedies bounces back in 2023 after sales slump in 2022
PROSPECTS AND OPPORTUNITIES
  • A modest performance ahead due to saturation and maturity
  • The longer allergy season set to support demand for antihistamines/allergy remedies
  • Medicated confectionery set to remain a huge and rather anomalous category
CATEGORY DATA
  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
  • Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2023
  • Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2023
  • Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2023-2028
  • Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN NORWAY
EXECUTIVE SUMMARY
  • Consumer health in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
  • Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2018-2023
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
  • Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
  • Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources